Induction of lung adenocarcinoma in transgenic mice expressing activated <i>EGFR</i> driven by the SP‐C promoter
Kadoaki Ohashi(Vanderbilt University), Katsuyuki Kiura(Okayama University Hospital)
Cited by 28
Related Papers
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i>
|Proceedings of the National Academy of Sciences|2012|436
Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
|Cancer Research|2016|128
Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells
|Molecular Cancer Therapeutics|2011|126